Search

Your search keyword '"Michinori Ishitoku"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Michinori Ishitoku" Remove constraint Author: "Michinori Ishitoku"
17 results on '"Michinori Ishitoku"'

Search Results

1. Expression of factor XIII originating from synovial fibroblasts and macrophages induced by interleukin-6 signaling

2. Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and design

3. Tumor Necrosis Factor and Interleukin-1β Upregulate NRP2 Expression and Promote SARS-CoV-2 Proliferation

4. Tumor Necrosis Factor and Interleukin-1β Upregulate NRP2 Expression and Promote SARS-CoV-2 Proliferation

6. Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).

7. Cryoglobulinemic Vasculitis Associated with Monoclonal Gammopathy of Undetermined Significance Developed after Sustained Virologic Response of Hepatitis C: A Case Report

8. Nailfold capillaries and myositis-specific antibodies in anti–melanoma differentiation–associated gene 5 antibody-positive dermatomyositis

9. Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus

11. N

12. Comment on: Nailfold capillaries and myositis-specific antibodies in anti-melanoma differentiation-associated gene 5 antibody-positive DM. Reply

13. The Lipopolysaccharide Mutant Re-LPS Is a Useful Tool for Detecting LPS Contamination in Rheumatoid Synovial Cell Cultures

14. The clinical characteristics and predictors of severe digital ischemia in patients with anti-aminoacyl transfer RNA synthetase antibodies

15. C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids

16. C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids.

17. AB1159 High dose glucocorticoids as a risk factor of sigmoid diverticulitis perforations in autoimmune diseases

Catalog

Books, media, physical & digital resources